Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy

References

• Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, Gamberini MR, et al. Survival and disease complications in thalassemia major. Ann N Y Acad Sci. 1998;850:227–31.
   PubMed Web of Science ®Google Scholar
• Piga A, Roggero S, Salussolia I, Massano D, Serra M, Longo F. Deferiprone. Ann N Y Acad Sci. 2010;1202:75–8.
   PubMed Web of Science ®Google Scholar
• Berdoukas V, Farmaki K, Carson S, Wood J, Coates T. Treating thalassemia major-related iron overload: the role of deferiprone. J Blood Med. 2012;3:119–29.
   PubMedGoogle Scholar
• Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet. 2002;360:516–20.
   PubMed Web of Science ®Google Scholar
• Aydinok Y, Darcan S, Polat A, Kavakli K, Nigli G, Coker M, et al. Endocrine complications in patients with beta-thalassemia major. J Trop Pediatr.2002;48:50–4.
   PubMed Web of Science ®Google Scholar
• Wang CH, Wu KH, Tsai FJ, Peng CT, Tsai CH. Comparison of oral and subcutaneous iron chelation therapies in the prevention of major endocrinopathies in beta-thalassemia major patients. Hemoglobin. 2006;30:257–62.
   PubMed Web of Science ®Google Scholar
• Farmaki K, Tzoumari I, Pappa C, Chouliaras G, Berdoukas V. Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassemia major. Br J Haematol. 2010;148:466–75.
   PubMed Web of Science ®Google Scholar
• Farmaki K, Tzoumari I, Pappa C. Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications. Blood Cells Molec Dis. 2011;47:33–40.
   PubMed Web of Science ®Google Scholar
• Gamberini MR, De Sanctis V, Gilli G. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassemia major followed from 1980 to 2007 in the Ferrara Centre. Pediatr Endocrinol Rev. 2008;6 (suppl 1):158–69.
   PubMedGoogle Scholar
• Platis O, Anagnostopoulos G, Farmaki K, Posantzis M, Gotsis E, Tolis G. Glucose metabolism disorders improvement in patients with thalassemia major after 24–36 months of intensive chelation therapy. Pediatr Endocrinol Rev. 2004;2 (suppl 2):279–81.
   PubMedGoogle Scholar
• Agarwal DK, Agarwal KN, Upadhyay SK, Mittal R, Prakash R, Rai S. Indian Pediatr. 1992;29:1203–82.
   Google Scholar
• Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976;51:170–9.
   PubMed Web of Science ®Google Scholar
• Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and the Wrist, 2nd edn. Stanford, CA: Stanford University Press, 1959.
   Google Scholar
• World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia. Report of a WHO/IDF consultation. Geneva: WHO, 2006.
   Google Scholar
• Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol (Oxf). 1995;42:581–6.
   PubMed Web of Science ®Google Scholar
• Gulati R, Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in beta- thalassemia major in a developing country. J Pediatr Endocrinol Metab. 2000;13:651–6.
   PubMed Web of Science ®Google Scholar
• Najafipour F, Aliasgarzadeh A, Aghamohamadzadeh N, Bahrami A, Mobasri M, Niafar M, et al. A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major. Ann Saudi Med. 2008;28:361–6.
   PubMed Web of Science ®Google Scholar
• Raiola G, Galati MC, De Sanctis V, Caruso Nicoletti M, Pintor C, De Simone M, et al. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab. 2003;16 (suppl 2):259–66.
   PubMed Web of Science ®Google Scholar
• Borgna-Pignatti C, De Stefano P, Zonta L, Vullo C, De Sanctis V, Melevendi C, et al. Growth and sexual maturation in thalassemia major. J Pediatr. 1985;106:150–5.
   PubMed Web of Science ®Google Scholar
• Toumba M, Sergis A, Kanaris C, Skordis N. Endocrine complications in patients with thalassaemia major. Pediatr Endocrinol Rev. 2007;5:642–8.
   PubMedGoogle Scholar
• Chern JP, Lin KH. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Pediatr Hematol Oncol. 2002;24:291–3.
   PubMed Web of Science ®Google Scholar
• Belhoul KM, Bakir ML, Saned MS, Kadhim AM, Musallam KM, Taher AT. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major. Ann Hematol. 2012;91:1107–14.
   PubMed Web of Science ®Google Scholar
• Chatterjee R, Bajoria R. Critical appraisal of growth retardation and pubertal disturbances in thalassemia. Ann NY Acad Sci. 2010;1202:100–14.
   PubMed Web of Science ®Google Scholar
• Mohammadian S, Bazrafshan HR, Sadeghi-Nejad A. Endocrine gland abnormalities in thalassemia major: a brief review. J Pediatr Endocrinol Metab. 2003;16:957–64.
   PubMed Web of Science ®Google Scholar
• Theodoridis C, Ladis V, Papatheodorou A, Berdousi H, Palamidou F, Evagelopoulou C, et al. Growth and management of short stature in thalassemia major. J Pediatr Endocrinol Metab. 1998;11 (suppl 3):835–44.
   PubMed Web of Science ®Google Scholar
• Roth C, Pekrun A, Bartz M, Jarry H, Eber S, Lakomek M, et al. Short stature and failure of pubertal development in thalassemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion. Eur J Pediatr. 1997;156:777–83.
   PubMed Web of Science ®Google Scholar
• Chrysis DC, Alexandrides TK, Koromantzou E, Georgopoulos N, Vassilakos P, Kiess W, et al. Novel application of IGF-I and IGFBP-3 generation tests in the diagnosis of growth hormone axis disturbances in children with beta-thalassemia. Clin Endocrinol (Oxf). 2001;54:253–9.
   PubMed Web of Science ®Google Scholar
• Wood JC, Noetzl L, Hyderi A, Joukar M, Coates T, Mittelman S. Predicting pituitary iron and endocrine dysfunction. Ann NY Acad Sci. 2010;1202:123–8.
   PubMed Web of Science ®Google Scholar